EQUUS TOTAL RETURN, INC. (EQS)
Strong H1 2026 business performance: H1 revenue of €124.5 million (+7.3% on a reported basis) and ARR of €111.1 million at 30 June 2026 (+8.8% vs. 30 June 2025)
Strong H1 2026 business performance: H1 revenue of €124.5 million (+7.3% on a reported basis) and ARR of €111.1 million at 30 June 2026 (+8.8% vs. 30 June 2025)
Oconee Federal Financial Corp. Announces Quarterly Dividend
Le CN soutient plus de 300 projets de croissance de la clientèle sur l’ensemble de son réseau
CN Supporting More Than 300 Customer Growth Projects Across Its Network
Octagon Denounces Decision by the Board of Trustees of XFLT to Delay the Shareholder Vote on the Proposed Sub-Adviser Transition
CAPR Stock Drop Alert: Capricor Therapeutics Stock Plummets Over 64% After FDA Briefing Documents Raise Concerns, Triggering Securities Fraud Investigation by BFA Law
Law Offices of Frank R. Cruz Encourages PROCEPT BioRobotics Corporation (PRCT) Shareholders To Inquire About Securities Fraud Class Action
Apogee Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apogee Therapeutics, Inc. - APGE
Kadant to Hold Earnings Conference Call on Wednesday, August 5, 2026
Law Offices of Frank R. Cruz Encourages Wix.com Ltd. (WIX) Shareholders To Inquire About Securities Fraud Class Action